IRIS Accounts Production v23.4.0.336 01584966 director 1.10.22 30.9.23 30.9.23 0 0 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh015849662022-09-30015849662023-09-30015849662022-10-012023-09-30015849662021-09-30015849662021-10-012022-09-30015849662022-09-3001584966ns15:EnglandWales2022-10-012023-09-3001584966ns14:PoundSterling2022-10-012023-09-3001584966ns10:Director12022-10-012023-09-3001584966ns10:PrivateLimitedCompanyLtd2022-10-012023-09-3001584966ns10:SmallEntities2022-10-012023-09-3001584966ns10:AuditExempt-NoAccountantsReport2022-10-012023-09-3001584966ns10:SmallCompaniesRegimeForDirectorsReport2022-10-012023-09-3001584966ns10:SmallCompaniesRegimeForAccounts2022-10-012023-09-3001584966ns10:FullAccounts2022-10-012023-09-3001584966ns10:OrdinaryShareClass12022-10-012023-09-3001584966ns10:RegisteredOffice2022-10-012023-09-3001584966ns5:CurrentFinancialInstruments2023-09-3001584966ns5:CurrentFinancialInstruments2022-09-3001584966ns5:ShareCapital2023-09-3001584966ns5:ShareCapital2022-09-3001584966ns5:CapitalRedemptionReserve2023-09-3001584966ns5:CapitalRedemptionReserve2022-09-3001584966ns5:RetainedEarningsAccumulatedLosses2023-09-3001584966ns5:RetainedEarningsAccumulatedLosses2022-09-3001584966ns5:CostValuation2022-09-3001584966ns5:DisposalsRepaymentsInvestments2023-09-3001584966ns5:CostValuation2023-09-3001584966ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-09-3001584966ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-09-3001584966ns10:OrdinaryShareClass12023-09-30
REGISTERED NUMBER: 01584966 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 September 2023

for

Bio-Nuclear Services Limited

Bio-Nuclear Services Limited (Registered number: 01584966)






Contents of the Financial Statements
for the Year Ended 30 September 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Bio-Nuclear Services Limited

Company Information
for the Year Ended 30 September 2023







DIRECTOR: Mr S J Anderson





REGISTERED OFFICE: Marland House
13 Huddersfield Road
Barnsley
South Yorkshire
S70 2LW





REGISTERED NUMBER: 01584966 (England and Wales)





ACCOUNTANTS: Harris & Co Limited
Chartered Accountants
Marland House
13 Huddersfield Road
Barnsley
South Yorkshire
S70 2LW

Bio-Nuclear Services Limited (Registered number: 01584966)

Balance Sheet
30 September 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Investments 5 84,400 84,401

CURRENT ASSETS
Debtors 6 188,002 -
Cash at bank 1,112,095 65,718
1,300,097 65,718
CREDITORS
Amounts falling due within one year 7 602 4,216
NET CURRENT ASSETS 1,299,495 61,502
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,383,895

145,903

CAPITAL AND RESERVES
Called up share capital 8 1,000 1,000
Capital redemption reserve 100 100
Retained earnings 1,382,795 144,803
SHAREHOLDERS' FUNDS 1,383,895 145,903

The Company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2023.

The members have not required the Company to obtain an audit of its financial statements for the year ended 30 September 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the Company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the Company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the Company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 25 March 2024 and were signed by:





Mr S J Anderson - Director


Bio-Nuclear Services Limited (Registered number: 01584966)

Notes to the Financial Statements
for the Year Ended 30 September 2023

1. STATUTORY INFORMATION

Bio-Nuclear Services Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation and functional currency of the financial statements is the Pound Sterling (£).

2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared on a going concern basis under the historical cost convention.

Significant judgements and estimates
The principal accounting policies and significant judgements and estimates applied in the preparation of these financial statements are set out below. These policies, judgements and estimates have been consistently applied to all years presented unless otherwise stated.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2022 - NIL).

Bio-Nuclear Services Limited (Registered number: 01584966)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2023

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
At 1 October 2022 84,401
Disposals (1 )
At 30 September 2023 84,400
NET BOOK VALUE
At 30 September 2023 84,400
At 30 September 2022 84,401

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Other debtors 188,002 -

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Other creditors 602 4,216

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
1,000 Ordinary £1 1,000 1,000